📇 Rhumatologue · PARIS · (75) · Salarié
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Auteur de référence en rhumatologie
21 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (1 thèse dirigée)
Expérience confirmée
32 ans d'exercice en rhumatologie — recul clinique solide
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
32ans d'exercice (thèse 1994)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Traumatisme par injection au membre superieur
Direction : Henry Bureau
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
In vivo efficacy proof of concept of a large-size bioprinted dermo-epidermal substitute for permanent wound coverage
2023ArticleFrontiers in Bioengineering and Biotechnology
Adipose Tissue and Adipose-Tissue-Derived Cell Therapies for the Treatment of the Face and Hands of Patients Suffering from Systemic Sclerosis
2023ArticleBiomedicines
Intra Articular Injection of Autologous Microfat and Platelets-Rich Plasma in the Treatment of Wrist Osteoarthritis: A Pilot Study
2022ArticleJournal of Clinical Medicine
Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions
2021ArticleCurrent Stem Cell Research & Therapy
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosis
2021ArticleRheumatology
Supportive use of platelet-rich plasma and stromal vascular fraction for cell-assisted fat transfer of skin radiation-induced lesions in nude mice
2020ArticleBurns
Alginate versus npwt in the preparation of surgical excisions for an stsg: atec trial
2020ArticlePlastic and Reconstructive Surgery, Global Open
Reply: The Use of Higher Proportions of Platelet-Rich Plasma to Enrich Microfat Has Negative Effects: A Preclinical Study
2020ArticlePlastic and Reconstructive Surgery
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CDS MEDICAL RAMSAY SANTE AUBER
9 R BOUDREAU, 75009 PARIS
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Current research in translational medicine · 2017
Stem cell research & therapy · 2014
Abstract Introduction Scleroderma is characterized by cutaneous manifestations that mainly affect the hands, arms and face. As of today, there is no treatment for fibrotic skin lesions of scleroderma. Previously we generated and validated a model of scleroderma-like skin sclerosis in nude mice, appropriate to inject human derived products. We showed that the subcutaneous injection of micro-fat (MF), purified and injected using small caliber cannulas, have anti-fibrotic and pro-angiogenic effects and appears more suitable for the treatment of skin lesions of scleroderma compared to the gold standard (Coleman’s technique or macro-fat). Here we compared the long-term efficacy of micro-fat “enriched” with other therapeutic products including the stromal vascular fraction (SVF) of fat and platelet-rich plasma (PRP) from blood in our murine model of scleroderma. Methods We used 72 nude mice in this study. We formed six experimental groups: Macro-fat, MF, SVF, PRP, MF + SVF, MF + PRP. This project has three phases: i) Induction of skin sclerosis by daily subcutaneous injections of bleomycin (BLM) for 4 weeks in nude mice; ii) Purification and injection of the different cell therapy products; iii) Histological analyses done 8 weeks post-injections. Results MF + SVF and MF + PRP significantly reversed dermal and epidermal sclerosis (P <0.01). Macro-fat, SVF, PRP only corrected the dermal sclerosis (P <0.05). Epidermal sclerosis was reduced in treatments containing MF (P <0.01). MF was more stable. Products containing the SVF were associated with a significant increase of the local vascularization (P <0.01). Conclusions All tested substances were effective in treating skin-induced lesions of scleroderma with different levels of fibrosis and vascular improvement; MF derived products are more stable and SVF demonstrated better pro-angiogenic effects. The observed efficacy of this combination of products in the animal model provides a rationale for potential clinical applications to treat human disease.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2024 · Journal Article
Witters M, Delgove A, Camuzard O, Bougie E, et al.
Biomedicines · 2023 · Journal Article
Coulange Zavarro A, Velier M, Arcani R, Abellan Lopez M, et al.
Journal of clinical medicine · 2022 · Journal Article
Mayoly A, Witters M, Jouve E, Bec C, et al.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2021 · Journal Article
Blayney F, Camuzard O, Klein A, Perchenet AS, et al.
Plastic and reconstructive surgery. Global open · 2020 · Journal Article
Casanova D, Guerreschi P, Sinna R, Bertheuil N, et al.
The American journal of medicine · 2019 · Case Reports
Jarrot PA, Pelletier ML, Brun M, Penicaud M, et al.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2018 · Comparative Study
Bergel C, Alshukry A, Kerfant N, Philandrianos C, et al.
Annals of plastic surgery · 2018 · Journal Article
Mayoly A, Mattei JC, Moullot P, Jaloux C, et al.
Current research in translational medicine · 2017 · Clinical Trial, Phase I
Daumas A, Magalon J, Jouve E, Truillet R, et al.
Acta neurochirurgica · 2016 · Case Reports
Jaloux C, Roche PH, Bertrand B, Casanova D, et al.
Lasers in surgery and medicine · 2015 · Evaluation Study
Philandrianos C, Bertrand B, Andrac-Meyer L, Magalon G, et al.
Stem cell research & therapy · 2021 · Journal Article
François P, Rusconi G, Arnaud L, Mariotta L, et al.
Annales de chirurgie plastique et esthetique · 2021 · Journal Article
Tourrier M, Honeyman CS, Lopez MA, Casanova D, et al.
Annales de chirurgie plastique et esthetique · 2023 · Journal Article
Abellan Lopez M, Philandrianos C, Daumas A, Velier M, et al.
Stem cell research & therapy · 2014 · Journal Article
Serratrice N, Bruzzese L, Magalon J, Véran J, et al.
Rheumatology (Oxford, England) · 2022 · Journal Article
Daumas A, Magalon J, Jouve E, Casanova D, et al.
Aesthetic surgery journal · 2015 · Case Reports
Bertrand B, Georgiou C, Degardin N, Bardot J, et al.
Cureus · 2023 · Case Reports
Correia de Sá A, Batista M, Ferreira AL, Casanova D, et al.
Pediatrics international : official journal of the Japan Pediatric Society · 2017 · Case Reports
Pascal S, Bettex Q, Andre N, Petit P, et al.
Annals of the rheumatic diseases · 2015 · Clinical Trial, Phase I
Granel B, Daumas A, Jouve E, Harlé JR, et al.
The National medical journal of India · 2018 · Journal Article
Kachouh N, Philandrianos C, Bertrand B, Casanova D
Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions
Abstract Background Even though the manufacturing processes of the stromal vascular fraction for clinical use are performed in compliance with the good manufacturing practices applying to advanced therapy medicinal produ
Additional file 1 of Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions
Additional file 1: Supplemental Table 1. Clinical trials of the AP-HM cohort. Detailed of the clinical trials whose patients were included in the study. ANSM : Agence nationale de sécurité du médicament et des produits d
Inter-center comparison of good manufacturing practices-compliant stromal vascular fraction and proposal for release acceptance criteria: a review of 364 productions
Abstract Background Even though the manufacturing processes of the stromal vascular fraction for clinical use are performed in compliance with the good manufacturing practices applying to advanced therapy medicinal produ
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).